Track the 셀루메드 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 셀루메드 has published 37 insider filings. Market capitalisation: €83.9bn. The latest transaction was disclosed on 23 March 2026 (Other). Among the most active insiders: 인스코비. Every trade is accessible without an account.
37
Insider Decl.
0
Thresholds
·
18 ops.
Buy Volume
·
2 ops.
Sell Volume
2Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 24,069 of 25,927 companies
18.7
score / 100
Value
23
Quality
14
FCF yld-4.9%
Earn yld-2.7%
EV/EBITDA·
ROE-14%
Gross mgn4.7%
Net mgn-1.6%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.